Skip to main content

Appriss Acquires Typhoon Data to Expand Healthcare Sanctions Data Offerings

Written by Customer Service on . Posted in Mergers And Acquisitions.

LOUISVILLE, Ky., Aug. 27, 2020 (GLOBE NEWSWIRE) — Appriss Inc., a leading provider of technology, data, and analytics solutions, today announced the acquisition of Typhoon Data, a top provider of healthcare sanctions and credentialing solutions.
“Appriss is committed to delivering the nation’s leading data and analytics platform to mitigate person-based risk in the workplace and in our communities,” said Krishnan Sastry, CEO of Appriss Inc. “Typhoon Data provides unique capabilities to help identify and mitigate risks associated with the healthcare industry, which represents nearly 14% of our nation’s workforce.”Typhoon Data will become part of the Appriss Insights data platform, delivering crucial risk-related information to the healthcare industry and further enhancing Appriss’ industry-leading data solutions. The acquisition is Appriss Insights’ first in an industry-specific solution, and is the fourth acquisition in the last two years, following HygenicsData (HDI), CrimeFinders Inc. (CFi), and Innovative Enterprises, Inc. (IEI). These transactions have strengthened Appriss’ position as a leading wholesale data provider and reinforce a commitment to unique data solutions.“Typhoon is excited to join Appriss in its mission of sharing knowledge for good and in its expansion of products that reduce healthcare workforce risk,” said Questin Francis, CEO of Typhoon Data. “Our shared commitment to partner success and product innovation ensures that healthcare organizations will have access to an unmatched portfolio of data solutions with the highest level of service and support.”Typhoon Data, a Utah-based company established in 2013, is the premier healthcare technology company focused on providing data products and services in healthcare compliance and professional credentialing to consumer reporting agencies (CRAs), credentials verification organizations (CVOs) and compliance companies. Through its unique data collection processes, state-of-the-art algorithms and integrations, Typhoon Data provides faster and more accurate data for healthcare organizations to ensure quality care and mitigate compliance risk.In 2017, Typhoon Data received the National Committee for Quality Assurance (NCQA) certification for its credentials verification services: License to Practice, DEA Registration, Medical Board Sanctions, Medicare/Medicaid Sanctions, and Ongoing Monitoring.“The addition of Typhoon Data further demonstrates Appriss’ continued investment and commitment to being a leading wholesale data provider in all of the markets that we serve,” said Brian Matthews, President of Appriss Insights. “The need for qualified, professional healthcare providers has never been greater. Our combined portfolio will facilitate faster, more comprehensive screening services for the healthcare industry. The information extends our platform with a leading asset in fighting healthcare fraud, waste and abuse.”For more information about Typhoon Data, visit their website at www.typhoondata.com.About Appriss® Insights

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.